Pooja Dassan, Martin M Brown, Simone M Gregoire, Geoffrey Keir, David J Werring
{"title":"Association of cerebral microbleeds in acute ischemic stroke with high serum levels of vascular endothelial growth factor.","authors":"Pooja Dassan, Martin M Brown, Simone M Gregoire, Geoffrey Keir, David J Werring","doi":"10.1001/archneurol.2012.459","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To determine whether vascular endothelial growth factor (VEGF) levels are associated with the presence of cerebral microbleeds (CMBs) in patients after acute ischemic stroke.</p><p><strong>Design: </strong>A cross-sectional study that used blood samples obtained within 24 hours of symptom onset from patients who experienced acute stroke to measure VEGF levels by enzyme immunoassay. A validated CMB rating scale was used to analyze acutely acquired magnetic resonance images, with the rater blind to clinical details and VEGF levels.</p><p><strong>Setting: </strong>Accident and Emergency Department at University College Hospital, London, England.</p><p><strong>Patients: </strong>Twenty patients who experienced acute ischemic stroke.</p><p><strong>Main outcome measures: </strong>Presence of CMBs and serum level of VEGF.</p><p><strong>Results: </strong>Five of the 20 patients with acute ischemic stroke (25%) had CMBs. The median VEGF level in the CMB group was significantly higher than that in the group without CMBs (P = .003).</p><p><strong>Conclusion: </strong>An increase in vascular permeability secondary to a raised VEGF level may have a role in the genesis of CMBs in patients with acute ischemic stroke.</p>","PeriodicalId":8321,"journal":{"name":"Archives of neurology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archneurol.2012.459","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/archneurol.2012.459","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 17
Abstract
Objective: To determine whether vascular endothelial growth factor (VEGF) levels are associated with the presence of cerebral microbleeds (CMBs) in patients after acute ischemic stroke.
Design: A cross-sectional study that used blood samples obtained within 24 hours of symptom onset from patients who experienced acute stroke to measure VEGF levels by enzyme immunoassay. A validated CMB rating scale was used to analyze acutely acquired magnetic resonance images, with the rater blind to clinical details and VEGF levels.
Setting: Accident and Emergency Department at University College Hospital, London, England.
Patients: Twenty patients who experienced acute ischemic stroke.
Main outcome measures: Presence of CMBs and serum level of VEGF.
Results: Five of the 20 patients with acute ischemic stroke (25%) had CMBs. The median VEGF level in the CMB group was significantly higher than that in the group without CMBs (P = .003).
Conclusion: An increase in vascular permeability secondary to a raised VEGF level may have a role in the genesis of CMBs in patients with acute ischemic stroke.